Register der Managementtransaktionen und bedeutenden Beteiligungen — Seite 3

Alle an SIX Exchange Regulation gemeldeten Transaktionen, die neuesten zuerst, mit Filtern nach Unternehmen, Richtung und Betrag.

KaufBeteiligungenMajor stake

Komax Holding AG

Heinz M. Buhofer · Group of shareholders

25%Erworbene Stimmrechte30.10.2026
KaufBeteiligungenThreshold crossing

Comet Holding AG

Swisscanto Fondsleitung AG · Collective investment vehicle

5.04%Erworbene Stimmrechte30.10.2026
KaufBeteiligungen

ARYZTA AG

BlackRock, Inc · Single shareholder

3.061%Erworbene Stimmrechte30.10.2026
SaleManagement-Transaktionen

Medacta Group SA

Executive member of the board of directors / senior management · Registered shares

CHF 238’9772’000 × CHF 119.4930.10.2026
SaleManagement-Transaktionen

Medacta Group SA

Executive member of the board of directors / senior management · Registered shares

CHF 99’102830 × CHF 119.4030.10.2026
SaleManagement-TransaktionenLarge transaction

Medacta Group SA

Executive member of the board of directors / senior management · Registered shares

CHF 539’9144’518 × CHF 119.5030.10.2026
SaleManagement-Transaktionen

Perrot Duval Holding SA

Executive member of the board of directors / senior management · Registered shares

CHF 102’0151’300 × CHF 78.4730.10.2026
SaleManagement-Transaktionen

Hypothekarbank Lenzburg AG

Non-executive member of the board of directors · Registered shares

CHF 12’6003 × CHF 4’20030.10.2026
PurchaseManagement-TransaktionenMajor transaction

Matador Secondary Private Equity AG

Executive member of the board of directors / senior management · Bearer shares

CHF 13’046’2203’236’600 × CHF 4.0330.10.2026
PurchaseManagement-TransaktionenMajor transaction

Matador Secondary Private Equity AG

Executive member of the board of directors / senior management · Bearer shares

CHF 13’046’2203’236’600 × CHF 4.0330.10.2026
SaleManagement-TransaktionenMajor transaction

PolyPeptide Group AG

Executive member of the board of directors / senior management · Other securities

CHF 6’321’929142’675 × CHF 44.3130.10.2026
SaleManagement-Transaktionen

PolyPeptide Group AG

Executive member of the board of directors / senior management · Other securities

CHF 296’3016’687 × CHF 44.3130.10.2026
SaleManagement-Transaktionen

PolyPeptide Group AG

Executive member of the board of directors / senior management · Other securities

CHF 156’7693’538 × CHF 44.3130.10.2026
SaleManagement-TransaktionenMajor transaction

PolyPeptide Group AG

Executive member of the board of directors / senior management · Registered shares

CHF 10’095’679227’842 × CHF 44.3130.10.2026
SaleManagement-Transaktionen

PolyPeptide Group AG

Non-executive member of the board of directors · Registered shares

CHF 190’0904’290 × CHF 44.3130.10.2026
SaleManagement-Transaktionen

PolyPeptide Group AG

Non-executive member of the board of directors · Registered shares

CHF 141’8193’193 × CHF 44.4230.10.2026
SaleManagement-TransaktionenLarge transaction

PolyPeptide Group AG

Non-executive member of the board of directors · Registered shares

CHF 1’316’09629’702 × CHF 44.3130.10.2026
SaleManagement-TransaktionenLarge transaction

PolyPeptide Group AG

Non-executive member of the board of directors · Registered shares

CHF 1’453’94432’813 × CHF 44.3130.10.2026
SaleManagement-TransaktionenLarge transaction

PolyPeptide Group AG

Non-executive member of the board of directors · Registered shares

CHF 2’008’08545’319 × CHF 44.3130.10.2026
SaleManagement-TransaktionenMajor transaction

Matador Secondary Private Equity AG

Executive member of the board of directors / senior management · Bearer shares

CHF 5’928’7201’411’600 × CHF 4.2030.10.2026
Unter dem SchwellenwertBeteiligungen

WISeKey International Holding AG

Moez Kassam · Single shareholder

3%Unter dem Schwellenwert29.10.2026
KaufBeteiligungenMajor stake

WISeKey International Holding AG

WISeQey Corp. · Single shareholder

100%Erworbene Stimmrechte29.10.2026
Unter dem SchwellenwertBeteiligungen

PolyPeptide Group AG

Maag Rudolf · Single shareholder

3%Unter dem Schwellenwert29.10.2026
Unter dem SchwellenwertBeteiligungen

PolyPeptide Group AG

Rudolf Maag · Single shareholder

3%Unter dem Schwellenwert29.10.2026
KaufBeteiligungenThreshold crossing

Landis+Gyr Group AG

Landis+Gyr Group AG · Single shareholder

10%Erworbene Stimmrechte29.10.2026

Source: SIX Exchange Regulation. Manager names are not published.